The Science Behind CBD: What Research From UPMC Reveals About Pain and Inflammation
If you’ve ever wondered whether CBD is backed by real science or just marketing buzz, the answer may surprise you. A white paper authored by Joseph C. Maroon, MD and Jeff Bost, PAC at the University of Pittsburgh Medical Center (UPMC) - one of the most respected academic medical centers in the country - takes a deep look at how cannabidiol (CBD) works in the body and why researchers believe it holds significant promise for pain, inflammation, and neurological health.
At Omax Health, we believe you deserve to understand what’s inside your products and why it works. Here’s a breakdown of what the science actually says.
Your Body Already Has a CBD System
Most people don’t realize that the human body is designed to interact with cannabinoids. The endocannabinoid system (ECS) is a natural signaling network in the body, complete with its own receptors, called CB1 and CB2 that are found throughout the brain, central nervous system, immune tissues, and peripheral nerves. This system plays a role in regulating inflammation, pain perception, neuroplasticity, and immune response.
CBD, the non-psychoactive compound derived from hemp, interacts with these receptors, particularly CB2, without producing any euphoric or intoxicating effects. That distinction matters. Unlike THC (the compound in marijuana that creates a “high”), CBD engages the ECS in a way that researchers believe supports anti-inflammatory and pain-modulating processes without altering mental state.
How CBD Works on Inflammation and Pain
The UPMC white paper highlights that CBD’s interaction with CB2 receptors, which are distributed widely in immune cells including lymphocytes, macrophages, microglial cells, and mast cells, helps reduce the inflammatory response at the cellular level. Specifically, research shows CBD can decrease the production of pro-inflammatory cytokines, reduce vascular cell adhesion molecules (VCAM-1), slow microglial migration, and decrease pro-inflammatory mediators like NF-kB and inducible nitric oxide synthase.
In plain terms: CBD tells your immune system to dial back the inflammatory alarm signal. For muscles and joints under stress from exercise, physical work, or everyday wear, that mechanism is directly relevant to how topical CBD application may help soothe soreness and stiffness.
Broad Body of Supporting Research
The UPMC white paper draws on research across multiple conditions to establish CBD’s anti-inflammatory and neuroprotective profile. In models of multiple sclerosis, stimulation of CB1 and CB2 receptors was found to be beneficial against the inflammatory process, and a 2014 review by the American Academy of Neurology, examining 34 studies, found strong support for cannabis-based medicine in reducing spasticity and spasticity-related pain.
In neurodegenerative models, CBD demonstrated the ability to decrease neuroinflammation and reduce vascular changes associated with tissue damage. Across conditions including anxiety, Parkinson’s disease, Alzheimer’s disease, and post-concussion syndrome, phytocannabinoids are now being actively studied for their anti-inflammatory and protective potential.
The Safety Profile: What Research Shows
One of the most compelling sections of the UPMC paper addresses safety. A comprehensive 2016 review of CBD across both animal and human studies found an excellent safety profile at a wide variety of doses. The most commonly reported side effects were mild - tiredness, digestive changes, and minor shifts in appetite. Importantly, high doses of CBD (up to 1500 mg/day) were well tolerated. Unlike THC, CBD does not alter heart rate, blood pressure, or body temperature, does not induce sedation, and does not affect psychomotor or psychological functions.
For topical use, such as a roll-on applied to a sore shoulder or tired knees, these findings provide a strong foundation for confidence. You’re getting the benefit of the CBD-ECS interaction at the site of application, without any systemic psychoactive effect.
Why This Matters for Omax's CryoFreeze® Products
CryoFreeze Hemp CBD Roll-On was built on this science. Each bottle contains 500mg of zero-THC hemp CBD delivered in a hands-free roll-on format designed for fast, targeted application to sore muscles and stiff joints. The cooling sensation works on contact while the CBD engages your body’s own endocannabinoid receptors to help modulate the inflammatory response beneath the surface.
This isn’t wellness theater. It’s a product grounded in the same scientific understanding that researchers at one of America’s top medical institutions have spent years studying.
←Back to Main Blog